189 related articles for article (PubMed ID: 25047205)
1. Ruling in or ruling out thyroid malignancy by molecular diagnostics of thyroid nodules.
Eszlinger M; Hegedüs L; Paschke R
Best Pract Res Clin Endocrinol Metab; 2014 Aug; 28(4):545-57. PubMed ID: 25047205
[TBL] [Abstract][Full Text] [Related]
2. Impact of molecular screening for point mutations and rearrangements in routine air-dried fine-needle aspiration samples of thyroid nodules.
Eszlinger M; Krogdahl A; Münz S; Rehfeld C; Precht Jensen EM; Ferraz C; Bösenberg E; Drieschner N; Scholz M; Hegedüs L; Paschke R
Thyroid; 2014 Feb; 24(2):305-13. PubMed ID: 23837487
[TBL] [Abstract][Full Text] [Related]
3. [Fine-needle aspiration cytology of thyroid nodules: molecular diagnostics in a routine diagnostic setting].
Eszlinger M; Neustadt M; Ruschenburg I; Neumann A; Franzius C; Adam S; Bacher K; Hach A; Hammoser R; Langvogt C; Molwitz T; Paschke R
Dtsch Med Wochenschr; 2014 Mar; 139(10):476-80. PubMed ID: 24570192
[TBL] [Abstract][Full Text] [Related]
4. Molecular analysis of residual ThinPrep material from thyroid FNAs increases diagnostic sensitivity.
Krane JF; Cibas ES; Alexander EK; Paschke R; Eszlinger M
Cancer Cytopathol; 2015 Jun; 123(6):356-61. PubMed ID: 25926393
[TBL] [Abstract][Full Text] [Related]
5. Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules.
Nikiforov YE; Steward DL; Robinson-Smith TM; Haugen BR; Klopper JP; Zhu Z; Fagin JA; Falciglia M; Weber K; Nikiforova MN
J Clin Endocrinol Metab; 2009 Jun; 94(6):2092-8. PubMed ID: 19318445
[TBL] [Abstract][Full Text] [Related]
6. Centralized molecular testing for oncogenic gene mutations complements the local cytopathologic diagnosis of thyroid nodules.
Beaudenon-Huibregtse S; Alexander EK; Guttler RB; Hershman JM; Babu V; Blevins TC; Moore P; Andruss B; Labourier E
Thyroid; 2014 Oct; 24(10):1479-87. PubMed ID: 24811481
[TBL] [Abstract][Full Text] [Related]
7. Next-Generation Sequencing Identifies Gene Mutations That Are Predictive of Malignancy in Residual Needle Rinses Collected From Fine-Needle Aspirations of Thyroid Nodules.
Fuller MY; Mody D; Hull A; Pepper K; Hendrickson H; Olsen R
Arch Pathol Lab Med; 2018 Feb; 142(2):178-183. PubMed ID: 28537807
[TBL] [Abstract][Full Text] [Related]
8. Next-generation sequencing improves the diagnosis of thyroid FNA specimens with indeterminate cytology.
Le Mercier M; D'Haene N; De Nève N; Blanchard O; Degand C; Rorive S; Salmon I
Histopathology; 2015 Jan; 66(2):215-24. PubMed ID: 24834793
[TBL] [Abstract][Full Text] [Related]
9. Targeted Next Generation Sequencing with ThyroSeq v2.1 for Indeterminate Thyroid Nodules in Clinical Practice.
Witt RL
Del Med J; 2016 Dec; 88(12):366-372. PubMed ID: 29461717
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of BRAF, RAS, RET/PTC, and PAX8/PPARg alterations in different Bethesda diagnostic categories: A multicentric prospective study on the validity of the 7-gene panel test in 1172 thyroid FNAs deriving from different hospitals in South Italy.
Bellevicine C; Migliatico I; Sgariglia R; Nacchio M; Vigliar E; Pisapia P; Iaccarino A; Bruzzese D; Fonderico F; Salvatore D; Biondi B; Masone S; Novizio V; Scavuzzo F; Serino D; De Palma M; Chiofalo MG; Botti G; Pezzullo L; Nuzzo V; Spiezia S; De Chiara G; Iorio S; Conzo G; Docimo G; Faggiano A; Bongiovanni M; Malapelle U; Colao A; Triassi M; Troncone G;
Cancer Cytopathol; 2020 Feb; 128(2):107-118. PubMed ID: 31821746
[TBL] [Abstract][Full Text] [Related]
11. Young investigator challenge: Can the Ion AmpliSeq Cancer Hotspot Panel v2 be used for next-generation sequencing of thyroid FNA samples?
Bellevicine C; Sgariglia R; Malapelle U; Vigliar E; Nacchio M; Ciancia G; Eszlinger M; Paschke R; Troncone G
Cancer Cytopathol; 2016 Nov; 124(11):776-784. PubMed ID: 27717198
[TBL] [Abstract][Full Text] [Related]
12. The molecular diagnosis and management of thyroid neoplasms.
Theoharis C; Roman S; Sosa JA
Curr Opin Oncol; 2012 Jan; 24(1):35-41. PubMed ID: 22123232
[TBL] [Abstract][Full Text] [Related]
13. Thyroid cytology smear slides: An untapped resource for ThyroSeq testing.
Nikiforova MN; Lepe M; Tolino LA; Miller ME; Ohori NP; Wald AI; Landau MS; Kaya C; Malapelle U; Bellevicine C; Troncone G; Nikiforov YE; Baloch Z
Cancer Cytopathol; 2021 Jan; 129(1):33-42. PubMed ID: 32697051
[TBL] [Abstract][Full Text] [Related]
14. Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples.
Nikiforov YE; Ohori NP; Hodak SP; Carty SE; LeBeau SO; Ferris RL; Yip L; Seethala RR; Tublin ME; Stang MT; Coyne C; Johnson JT; Stewart AF; Nikiforova MN
J Clin Endocrinol Metab; 2011 Nov; 96(11):3390-7. PubMed ID: 21880806
[TBL] [Abstract][Full Text] [Related]
15. Simultaneously Detection of 50 Mutations at 20 Sites in the BRAF and RAS Genes by Multiplexed Single-Nucleotide Primer Extension Assay Using Fine-Needle Aspirates of Thyroid Nodules.
Stence AA; Gailey MP; Robinson RA; Jensen CS; Ma D
Yale J Biol Med; 2015 Dec; 88(4):351-8. PubMed ID: 26604858
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic Limitation of Fine-Needle Aspiration (FNA) on Indeterminate Thyroid Nodules Can Be Partially Overcome by Preoperative Molecular Analysis: Assessment of RET/PTC1 Rearrangement in BRAF and RAS Wild-Type Routine Air-Dried FNA Specimens.
Ko YS; Hwang TS; Kim JY; Choi YL; Lee SE; Han HS; Kim WS; Kim SK; Park KS
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28417935
[TBL] [Abstract][Full Text] [Related]
17. Centrifuged supernatants from FNA provide a liquid biopsy option for clinical next-generation sequencing of thyroid nodules.
Ye W; Hannigan B; Zalles S; Mehrotra M; Barkoh BA; Williams MD; Cabanillas ME; Edeiken-Monroe B; Hu P; Duose D; Wistuba II; Medeiros LJ; Stewart J; Luthra R; Roy-Chowdhuri S
Cancer Cytopathol; 2019 Mar; 127(3):146-160. PubMed ID: 30620446
[TBL] [Abstract][Full Text] [Related]
18. [Next generation sequencing].
Le Mercier M; D'Haene N; Rorive S; Degand C; De Nève N; Blanchard O; Salmon I
Rev Med Brux; 2016; 37(5):436-438. PubMed ID: 28525213
[TBL] [Abstract][Full Text] [Related]
19. Molecular pathology and thyroid FNA.
Poller DN; Glaysher S
Cytopathology; 2017 Dec; 28(6):475-481. PubMed ID: 29165888
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic potential of ancillary molecular testing in differentiation of benign and malignant thyroid nodules.
Bhatia P; Deniwar A; Friedlander P; Aslam R; Kandil E
Anticancer Res; 2015 Mar; 35(3):1237-41. PubMed ID: 25750270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]